Chemical activation with a combination of ionomycin and dehydroleucodine for production of parthenogenetic, ICSI and cloned bovine embryos

Contents: The aim of this study was to evaluate the potential of dehydroleucodine [DhL], a new drug isolated from a medicinal herb used in Argentina, for activation of bovine oocyte. Several DhL concentrations and exposure times after ionomycin [Io] treatment were tested. The optimal DhL treatment,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Otros Autores: Vichera, Gabriel Damián, Alfonso, J., Duque, C. C., Silvestre, M. A., Pereyra Bonnet, Federico, Fernández Martín, Rafael, Salamone, Daniel Felipe
Formato: Artículo
Lenguaje:Inglés
Materias:
Acceso en línea:http://ri.agro.uba.ar/files/intranet/articulo/2010Vichera.pdf
LINK AL EDITOR
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 07681cab a22016697a 4500
001 AR-BaUFA000089
003 AR-BaUFA
005 20220808101657.0
008 181208t2010 |||||o|||||00||||eng d
999 |c 46523  |d 46523 
022 |a 0936-6768 
024 |a 10.1111/j.1439-0531.2009.01563.x 
040 |a AR-BaUFA  |c AR-BaUFA 
245 1 0 |a Chemical activation with a combination of ionomycin and dehydroleucodine for production of parthenogenetic, ICSI and cloned bovine embryos 
520 |a Contents: The aim of this study was to evaluate the potential of dehydroleucodine [DhL], a new drug isolated from a medicinal herb used in Argentina, for activation of bovine oocyte. Several DhL concentrations and exposure times after ionomycin [Io] treatment were tested. The optimal DhL treatment, found for parthenogenetic development, was employed to produce bovine embryos by intracytoplasmic sperm injection [ICSI] and somatic cell nuclear transfer [SCNT]. The best parthenogenic embryo developments were observed with 5 um Io for 4 min followed by 5 um DhL concentration and after 3-h exposure time [52.3 percent cleavage; 17.4 percent morulae; 7.3 percent blastocyst; n = 109]. This treatment generated no significant differences with standard Io plus 6-dimethylaminopurine [DMAP] treatment in preimplantation embryo development. In our conditions, the embryo development reached after ICSI and SCNT assisted by the DhL treatment did not differ in terms of cleavage and blastocyst development from activation with standard Io plus DMAP treatment [p greather than 0.05]. In conclusion, DhL utilization to activate oocytes and induce development of parthenogenotes, ICSI-embryos or SCNT-embryos is reported here for first time. 
653 0 |a DEHYDROLEUCODINE 
653 0 |a IONOMYCIN 
653 0 |a LACTONE 
653 0 |a SESQUITERPENE 
653 0 |a ANIMAL 
653 0 |a ANIMAL DISEASE 
653 0 |a ANIMAL EMBRYO 
653 0 |a CELL NUCLEUS TRANSPLANTATION 
653 0 |a CHEMICAL STRUCTURE 
653 0 |a CHEMISTRY 
653 0 |a CLONING 
653 0 |a DRUG EFFECT 
653 0 |a EMBRYO DEVELOPMENT 
653 0 |a INTRACYTOPLASMIC SPERM INJECTION 
653 0 |a OOCYTE 
653 0 |a PARTHENOGENESIS 
653 0 |a PRENATAL DEVELOPMENT 
653 0 |a ANIMALS 
653 0 |a CATTLE 
653 0 |a CLONING, ORGANISM 
653 0 |a EMBRYO, MAMMALIAN 
653 0 |a EMBRYONIC DEVELOPMENT 
653 0 |a IONOMYCIN 
653 0 |a LACTONES 
653 0 |a MOLECULAR STRUCTURE 
653 0 |a NUCLEAR TRANSFER TECHNIQUES 
653 0 |a OVUM 
653 0 |a PARTHENOGENESIS 
653 0 |a SESQUITERPENES 
653 0 |a SPERM INJECTIONS, INTRACYTOPLASMIC 
653 0 |a BOVINAE 
700 1 |9 34779  |a Vichera, Gabriel Damián 
700 1 |a Alfonso, J.  |9 69493 
700 1 |a Duque, C. C.  |9 69494 
700 1 |9 69495  |a Silvestre, M. A. 
700 1 |9 33719  |a Pereyra Bonnet, Federico 
700 1 |9 33720  |a Fernández Martín, Rafael 
700 1 |9 61021  |a Salamone, Daniel Felipe 
773 |t Reproduction in Domestic Animals  |g Vol.45, no.6 (2010), p.e306-e312 
856 |u http://ri.agro.uba.ar/files/intranet/articulo/2010Vichera.pdf  |i En reservorio  |q application/pdf  |f 2010Vichera  |x MIGRADOS2018 
856 |u http://www.wiley.com/  |x MIGRADOS2018  |z LINK AL EDITOR 
900 |a as 
900 |a 20131220 
900 |a N 
900 |a SCOPUS 
900 |a a 
900 |a s 
900 |a ARTICULO 
900 |a EN LINEA 
900 |a 09366768 
900 |a 10.1111/j.1439-0531.2009.01563.x 
900 |a ^tChemical activation with a combination of ionomycin and dehydroleucodine for production of parthenogenetic, ICSI and cloned bovine embryos 
900 |a ^aVichera^bG. 
900 |a ^aAlfonso^bJ. 
900 |a ^aDuque^bC.C. 
900 |a ^aSilvestre^bM.A. 
900 |a ^aPereyra-Bonnet^bF. 
900 |a ^aFernández-Martín^bR. 
900 |a ^aSalamone^bD. 
900 |a ^aVichera^bG. 
900 |a ^aAlfonso^bJ. 
900 |a ^aDuque^bC. C. 
900 |a ^aSilvestre^bM. A. 
900 |a ^aPereyra Bonnet^bF. 
900 |a ^aFernández Martín^bR. 
900 |a ^aSalamone^bD. F. 
900 |a ^aVichera, G.^tLaboratorio de Biotecnología Animal, Facultad de Agronomía, Universidad de Buenos Aires, Buenos Aires, Argentina 
900 |a ^aAlfonso, J.^tInstituto de Medicina Reproductiva [IMER], Valencia, Spain 
900 |a ^aDuque, C.C.^tUnidad de Reproducción Humana. H. U. La Fe, Valencia, Spain 
900 |a ^aSilvestre, M.A.^tCentro de Tecnología Animal, Instituto Valenciano de Investigaciones Agrarias, Segorbe, Spain 
900 |a ^aPereyra-Bonnet, F.^t 
900 |a ^aFernández-Martín, R.^t 
900 |a ^aSalamone, D.^t 
900 |a ^tReproduction in Domestic Animals^cReprod. Domest. Anim. 
900 |a en 
900 |a e306 
900 |a ^i 
900 |a Vol. 45, no. 6 
900 |a e312 
900 |a DEHYDROLEUCODINE 
900 |a IONOMYCIN 
900 |a LACTONE 
900 |a SESQUITERPENE 
900 |a ANIMAL 
900 |a ANIMAL DISEASE 
900 |a ANIMAL EMBRYO 
900 |a CELL NUCLEUS TRANSPLANTATION 
900 |a CHEMICAL STRUCTURE 
900 |a CHEMISTRY 
900 |a CLONING 
900 |a DRUG EFFECT 
900 |a EMBRYO DEVELOPMENT 
900 |a INTRACYTOPLASMIC SPERM INJECTION 
900 |a OOCYTE 
900 |a PARTHENOGENESIS 
900 |a PRENATAL DEVELOPMENT 
900 |a ANIMALS 
900 |a CATTLE 
900 |a CLONING, ORGANISM 
900 |a EMBRYO, MAMMALIAN 
900 |a EMBRYONIC DEVELOPMENT 
900 |a IONOMYCIN 
900 |a LACTONES 
900 |a MOLECULAR STRUCTURE 
900 |a NUCLEAR TRANSFER TECHNIQUES 
900 |a OVUM 
900 |a PARTHENOGENESIS 
900 |a SESQUITERPENES 
900 |a SPERM INJECTIONS, INTRACYTOPLASMIC 
900 |a BOVINAE 
900 |a Contents: The aim of this study was to evaluate the potential of dehydroleucodine [DhL], a new drug isolated from a medicinal herb used in Argentina, for activation of bovine oocyte. Several DhL concentrations and exposure times after ionomycin [Io] treatment were tested. The optimal DhL treatment, found for parthenogenetic development, was employed to produce bovine embryos by intracytoplasmic sperm injection [ICSI] and somatic cell nuclear transfer [SCNT]. The best parthenogenic embryo developments were observed with 5 um Io for 4 min followed by 5 um DhL concentration and after 3-h exposure time [52.3 percent cleavage; 17.4 percent morulae; 7.3 percent blastocyst; n = 109]. This treatment generated no significant differences with standard Io plus 6-dimethylaminopurine [DMAP] treatment in preimplantation embryo development. In our conditions, the embryo development reached after ICSI and SCNT assisted by the DhL treatment did not differ in terms of cleavage and blastocyst development from activation with standard Io plus DMAP treatment [p greather than 0.05]. In conclusion, DhL utilization to activate oocytes and induce development of parthenogenotes, ICSI-embryos or SCNT-embryos is reported here for first time. 
900 |a 45 
900 |a 6 
900 |a 2010 
900 |a ^cH 
900 |a AAG 
900 |a AGROVOC 
900 |a 2010Vichera 
900 |a AAG 
900 |a http://ri.agro.uba.ar/files/intranet/articulo/2010Vichera.pdf 
900 |a 2010Vichera.pdf 
900 |a http://www.wiley.com/ 
900 |a http://www.scopus.com/inward/record.url?eid=2-s2.0-78649587928&partnerID=40&md5=3b3fac01fbaf6cb98a250bffa56c34f3 
900 |a ^a^b^c^d^e^f^g^h^i 
900 |a OS 
942 0 0 |c ARTICULO  |2 udc 
942 0 0 |c ENLINEA  |2 udc